Effects of Release-Active Antibodies to CD4 Receptor on the Level of lck-Kinase in Cultured Mononuclear Cells from Human Peripheral Blood


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Только для подписчиков

Аннотация

For evaluation of effects of release-active antibodies to CD4 on cultured lymphocytes from human peripheral blood, we measured intracellular content of lck-kinase cell-based ELISA. In cells treated with release-active antibodies to CD4, the content of intracellular lck-kinase significantly (p<0.01) decreased in comparison with the control (purified water processed in a similar way). Phytohemagglutinin had no effect on the concentration of lck-kinase in cells. The decrease in the content of CD4-associated lck protein suggests that the preparation enhanced intracellular coupling of lck-kinase with T-cell receptor and potentiated T-cell immune response.

Об авторах

A. Emel’yanova

1Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathophysiology, Research Institute of General Pathology and Pathophysiology

Автор, ответственный за переписку.
Email: agemelyanova@gmail.com
Россия, Moscow

V. Grechenko

Research and Production Company Materia Medica Holding

Email: agemelyanova@gmail.com
Россия, Moscow

N. Petrova

1Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathophysiology, Research Institute of General Pathology and Pathophysiology

Email: agemelyanova@gmail.com
Россия, Moscow

I. Shilovskii

State Research Centre Institute of Immunology, Federal Medical-Biological Agency of the Russian Federation

Email: agemelyanova@gmail.com
Россия, Moscow

E. Gorbunov

Research and Production Company Materia Medica Holding

Email: agemelyanova@gmail.com
Россия, Moscow

S. Tarasov

Research and Production Company Materia Medica Holding

Email: agemelyanova@gmail.com
Россия, Moscow

M. Khaitov

State Research Centre Institute of Immunology, Federal Medical-Biological Agency of the Russian Federation

Email: agemelyanova@gmail.com
Россия, Moscow

S. Morozov

1Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathophysiology, Research Institute of General Pathology and Pathophysiology

Email: agemelyanova@gmail.com
Россия, Moscow

O. Epshtein

1Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathophysiology, Research Institute of General Pathology and Pathophysiology

Email: agemelyanova@gmail.com
Россия, Moscow


© Springer Science+Business Media New York, 2017

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах